Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Review Erowid at GreatNonprofits.org
Help us be a 2021 "Top Rated Nonprofit", and spread accurate info
about psychoactive drugs, health, culture, & policies.
("Share Your Story" link. Needs quick login creation but no verification of contact info)
DOM
Timeline
by Erowid
Dec 1, 1963 DOM is first synthesized by Alexander Shulgin in 1963 and is first bio-assayed in December of that year. 1  
1967 DOM (STP) first appears on the street in San Francisco, sometimes being confused with LSD and causing problems due to its long duration. 2  
Jan 25, 1967 Alexander Shulgin gives first public presentation mentioning DOM at Johns Hopkins. 3   [Details]
Jun 21, 1967 "Love-In" in San Francisco thousands of doses of DOM (STP) were distributed for free, unfortunately, they were distributed in approximately 10-15 mg doses, 5-10 times higher than Shulgin had recommended, and many people were hospitalized after getting way too high. 4, 5, 6   [Details]
1967 Nov 10-11 Approximately 5,000 "pink wedges" were consumed in San Francisco containing 270 micrograms of LSD and 970 micrograms of DOM (STP). 7  
Apr 2, 1968 DOM (STP) was placed under DACA control in the United States, making it illegal to possess, sell, or manufacture except for personal use. 8  
Sep 21, 1973 DOM is placed in Schedule I of the CSA in the U.S. making it illegal to buy, sell, or possess. 9  


References
  1.   Shulgin AT. Pharmacology Notes I. Page 84
  2.   Lee MA, Shlain B. Acid Dreams: The CIA, LSD and the Sixties Rebellion. Grove, 1985.
  3.   Shulgin AT. Awaiting Reference. Shulgin Collection. Erowid.
  4.   Bureau of Drug Abuse Control. Micro-Gram. Nov 1967;1(1):1-2.
  5.   Bureau of Narcotics and Dangerous Drugs. Microgram. May 1968;1(8):2.
  6.   Scully T. Personal Communication with Trout and Erowid. 2021.
  7.   Smith DE. "The Psychotomimetic Amphetamines with Special Reference to DOM (STP) Toxicity". Journal of Psychedelic Drugs. 1969. 2(2):37-41.
  8.   Bureau of Narcotics and Dangerous Drugs. MicroGram. Apr 1968;1(7):1.
  9.   38 FR 26447